EPISODE · May 9, 2026 · 9 MIN
SHTG Digest — Saturday May 9, 2026
from SHTG Daily Digest — Weiss Lab
No top-tier journal acromegaly-style hits this cycle, but the broader lipid literature delivered two useful APOC3-inhibitor / olezarsen meta-analyses and a timely RNAi-for-lipid-disorders review; Part B was a quiet news week for Arrowhead, Alnylam, and Ionis specifically, with the Tryngolza severe-hypertriglyceridemia FDA decision (due by June 30) the dominant near-term catalyst.
Embed this episode
NOW PLAYING
SHTG Digest — Saturday May 9, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.